中国实验血液学杂志2024,Vol.32Issue(2) :439-444.DOI:10.19746/j.cnki.issn1009-2137.2024.02.018

基线PET/CT显像骨髓18F-FDG摄取模式预测DLBCL预后的价值

The Value of Baseline PET/CT Imaging of Bone Marrow 18F-FDG Uptake Pattern in Predicting Prognosis of DLBCL

王媛 赵铭 原凌 李娟
中国实验血液学杂志2024,Vol.32Issue(2) :439-444.DOI:10.19746/j.cnki.issn1009-2137.2024.02.018

基线PET/CT显像骨髓18F-FDG摄取模式预测DLBCL预后的价值

The Value of Baseline PET/CT Imaging of Bone Marrow 18F-FDG Uptake Pattern in Predicting Prognosis of DLBCL

王媛 1赵铭 2原凌 2李娟1
扫码查看

作者信息

  • 1. 山西医科大学医学影像学系,山西太原 030001
  • 2. 山西省肿瘤医院PET-CT中心,山西太原 030013
  • 折叠

摘要

目的:探讨弥漫大B细胞淋巴瘤(DLBCL)治疗前18F-脱氧葡萄糖(18F-FDG)PET/CT显像中骨髓摄取模式对预测DLBCL患者预后的价值.方法:回顾性分析156例DLBCL患者的临床资料,所有患者治疗前均行骨髓活检、骨髓涂片、流式细胞分析和18F-FDG PET/CT扫描.以正常肝脏18F-FDG摄取为标准,将患者骨髓摄取模式分为骨髓摄取局灶型增高(fPET+)、骨髓摄取弥漫型增高(dPET+)及骨髓摄取正常型(nPET).生存分析采用Kaplan-Meier法,组间差异比较采用log-rank检验,采用多因素Cox回归分析确定与预后相关的危险因素.结果:156例患者中,fPET+17例,dPET+28例,nPET 111例.临床诊断骨髓浸润阳性21例,阴性135例.复发进展62例,死亡18例.单因素分析显示,Ann Arbor分期Ⅲ/Ⅳ期、B症状、NCCN-IPI评分、乳酸脱氢酶、骨髓浸润及fPET+与患者无进展生存期(PFS)有关(均P<0.05);Ann Arbor分期Ⅲ/Ⅳ期、NCCN-IPI评分、乳酸脱氢酶、骨髓浸润及fPET+与患者总生存期(OS)有关(均P<0.05);多因素分析显示,Ann Arbor分期Ⅲ/Ⅳ期、乳酸脱氢酶和fPET+(均P<0.05)是PFS独立预测因子.在OS的多变量分析中没有独立预测因子.结论:DLBCL患者治疗前18F-FDG显像中骨髓摄取模式对预后有预测价值,fPET+是患者PFS的独立危险因素.

Abstract

Objective:To investigate the prognostic value of bone marrow uptake pattern in18F-deoxyglucose(18F-FDG)PET/CT imaging before diffuse large B-cell lymphoma(DLBCL)treatment.Methods:The clinical data of 156 patients with DLBCL were retrospectively analyzed.All patients underwent bone marrow biopsy,bone marrow smear,flow cytometry and 18F-FDG PET/CT scan before treatment.Taking normal liver 18F-FDG uptake as the standard,the bone marrow uptake patterns of patients were divided into three types:focal increased bone marrow uptake(fPET+),diffusely increased bone marrow uptake(dPET+),and normal bone marrow uptake(nPET).Survival analysis was performed using the Kaplan-Meier method,log-rank test was used for comparison of differences between groups,and multivariate Cox regression analysis was used to identify risk factors associated with prognosis.Results:Among the 156 patients,17 cases were fPET+,28 cases were dPET+,and 111 cases were nPET.Clinical diagnosis of bone marrow infiltration(BMI)was positive in 21 cases and negative in 135 cases.There were 62 cases of recurrence and progression,and 18 cases of death.Univariate analysis showed that Ann Arbor stage Ⅲ/Ⅳ,B symptoms,NCCN-IPI score,lactate dehydrogenase(LDH),BMI+and fPET+were associated with progression-free survival(PFS)(all P<0.05),while Ann Arbor stage Ⅲ/Ⅳ,NCCN-IPI score,LDH,BMI+and fPET+were associated with overall survival(OS)(all P<0.05).Multivariate analysis showed that Ann Arbor stage Ⅲ/Ⅳ,LDH and fPET+were independent predictors of PFS(all P<0.05).There were no independent predictors of OS in multivariate analysis.Conclusion:The bone marrow uptake pattern of 18F-FDG imaging in DLBCL patients before treatment has a predictive value for DLBCL,while fPET+is an independent risk factor for PFS.

关键词

弥漫大B细胞淋巴瘤/骨髓穿刺活检/正电子发射断层显像/计算机断层扫描/18氟代脱氧葡萄糖/预后

Key words

diffuse large B-cell lymphoma/bone marrow biopsy/positron emission tomography/computed tomography/18F-deoxyglucose/prognosis

引用本文复制引用

出版年

2024
中国实验血液学杂志
中国病理生理学会

中国实验血液学杂志

CSTPCD北大核心
影响因子:0.988
ISSN:1009-2137
参考文献量13
段落导航相关论文